Management of neuropathic pain following treatment for breast cancer in the absence of recurrence: A challege for the radiation oncologist
This report reviews various management options for treatment-induced neuropathic pain in breast cancer. First-line options include tricyclic antidepressants and anticonvulsant drugs. Opioids should be prescribed according to published guidelines. Second-line treatments include lignocaine, mexiletine and ketamine. Sympatholytic therapies are available to patients with features of chronic regional pain syndrome. Anti-inflammatory agents are used for neurogenic inflammation. Surgical interventions...[Show more]
|Collections||ANU Research Publications|
|01_Clubb_Management_of_neuropathic_pain_2004.pdf||96.52 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.